Maxime Dely Suggested New Algorithm to Choose Blood Donor
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:
“What if blood transfusion was… Tinder?
Today, algorithms shape almost everything: the music we listen to, the routes we take… and even the people we meet.
So why not push the analogy all the way to blood transfusion?
Just like on Tinder, everything starts with a matchmaking process: on one side a donor, on the other a patient. The goal? Finding the perfect match.
And in both cases… you’d rather avoid a bad date.
Except in medicine, the algorithm is far more demanding:
ABO blood group typing,
Rh factor,
Crossmatching,
Antibody screening,
Verification of immunological compatibility…
A scientific “swipe” ensuring no immune reaction ruins the meeting between these two profiles.
When everything aligns, we get the key moment:
It’s a match!
No pink animation, but a compatibility that can stabilize, treat, or save a life.
In the end, Tinder or transfusion—it’s the same logic:
- Find the right connection,
- Avoid incompatibilities,
- Make sure the match actually works.
And maybe the most meaningful match of all… is the one created when you donate blood.”
Never miss an update from Hemostasis Today.
-
Jun 10, 2026, 18:09Leonard Valentino: Innovation in Blood Disorders Being Catalyzed by Pathway to Cures
-
Jun 10, 2026, 18:00Smitirupa Mishra: Normal Hemoglobin Does Not Always Mean Normal Genes
-
Jun 10, 2026, 17:58Talat Uppal: Addressing HMB with RACGP’s Dr. Ramya Raman
-
Jun 10, 2026, 17:52Throw Back Thursday to Past Bruises Posted in the Glanzmann’s Research Foundation
-
Jun 10, 2026, 17:52Priya Prasad: In Massive Hemorrhage, Fibrinogen Is Often the First Clotting Factor to Fall
-
Jun 10, 2026, 17:51Mariam Swidan: Some Red Blood Cells Can’t Handle Pressure
-
Jun 10, 2026, 17:49Ankit Mathur: Hosting ISBT Academy Day on Rare Donor Program in India
-
Jun 10, 2026, 17:48Shadi Tabibian: When Patients Bleed but Standard Testing Is Normal
-
Jun 10, 2026, 17:47Mervyn Morgan: Discussing Current ITP Research at Imperial College London